UPADACITINIB, 97%, 5g

3-Ethynyl-N-methylaniline, 97%, 1g

N~1~-(2-methylphenyl)-beta-alaninamide hydrochloride, 95.0%, 1g

Cobalt rod 99.95% 2 mm diameter 50 mm

1-N-Boc-3-(4-Bromophenoxy)pyrrolidine, 97.0%, 5g

tert-butyl (3R)-3-fluoro-4-oxopiperidine-1-carboxylate, 95.0%, 500mg

2-Fluoro-4-(4-methylpiperazin-1-yl)benzaldehyde, 95.0%, 100mg

Analytical and precision scale Entris® II series Models with external adjustment, not certified, 0.01 g, 3200 g, BCE3202-1S

4-(4,4,5,5-Tetramethyl-1,3,2-dioxaborolan-2-yl)benzoic Acid>98.0%(GC)(T)1g

6-Bromo-2-oxo-1,2-dihydroquinoline-4-carboxylic acid, 95.0%, 1g

tert-Butyl (3-aminopyridin-2-yl)carbamate, 95.0%, 50mg

(Z)-Methyl 3-(((4-(methylamino)phenyl)amino)(phenyl)methylene)-2-oxoindoline-6-carboxylate (Nintedanib Impurity), 97%, 50mg

(S)-4-Hydroxypiperidin-2-one, 95.0%, 5g